News EU-US trade deal includes 15% pharma tariff Details have been published of the trade agreement between the US and EU, with confirmation of the tariff rates for pharmaceuticals.
News Trump orders stockpiling of essential medicine ingredients Trump has ordered the creation of a six-month stockpile of ingredients to make essential medicines, in another part of his push to reshore production.
News Pharma tariffs set to arrive with US-EU trade deal After some initial confusion, it has been confirmed that the 15% tariff rate on US imports from the EU will extend to pharmaceuticals.
News Generic drugmaker Hikma pledges $1bn in US investment With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.
News Sanofi pledges a $20 billion investment programme in the US Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US.
News Pharma still in waiting mode after UK-US trade agreement Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals proved optimistic.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
